Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 2086 AL 2100

The neuroinflammatory role of microRNAs in Alzheimer's disease: pathological insights to therapeutic potential

Liu W, Rao X, Sun W, Chen X, Yu L, Zhang J, Chen J, Zheng X.

Mol Cell Biochem. 2025 May;480(5):2689-2706. doi: 10.1007/s11010-024-05164-0. Epub 2024 Nov 20.

Integrating artificial intelligence with small molecule therapeutics and precision medicine for neurochemical understanding of Alzheimer's diseases

Alshehri ZS.

Neuroscience. 2025 Nov 1;586:44-57. doi: 10.1016/j.neuroscience.2025.08.055. Epub 2025 Sep 18.

Fast Declining Prediction in Alzheimer's Disease from Early Clinical Assessment

Alvarez-Sanchez L, Pereto M, Garcia-Valles L, Balaguer A, Pena-Bautista C, Ferre-Gonzalez L, Baquero M, Pericas CC.

Curr Neuropharmacol. 2025;23(5):602-611. doi: 10.2174/011570159X332930240925095423.

Preclinical Cognitive Markers of Alzheimer Disease and Early Diagnosis Using Virtual Reality and Artificial Intelligence: Literature Review

Scribano Parada MP, González Palau F, Valladares Rodríguez S, Rincon M, Rico Barroeta MJ, García Rodriguez M, Bueno Aguado Y, Herrero Blanco A, Díaz-López E, Bachiller Mayoral M, Losada Durán R.

JMIR Med Inform. 2025 Jan 28;13:e62914. doi: 10.2196/62914.

Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study

Guillén N, Contador J, Buongiorno M, Álvarez I, Culell N, Alcolea D, Lleó A, Fortea J, Piñol-Ripoll G, Carnes-Vendrell A, Lourdes Ispierto M, Vilas D, Puig-Pijoan A, Fernández-Lebrero A, Balasa M, Sánchez-Valle R, Lladó A.

Eur Arch Psychiatry Clin Neurosci. 2025 Feb;275(1):257-266. doi: 10.1007/s00406-023-01701-y. Epub 2023 Oct 28.

The diagnostic value of plasma Aβ42 and Aβ40 in Alzheimer's disease: current status, challenges, and impacting variables

Duan X, Wang F, Liu W, Xie Y, Yang M, Ping Y, Yu P, Wei Z, Li H, Zhang Q, Wang X, Tao Z.

J Neurol. 2025 Dec 17;273(1):30. doi: 10.1007/s00415-025-13346-z.

Brain outcomes with lifestyle change in adults with Down syndrome: Rationale and design for a 12-month randomized trial

Ptomey LT, Donnelly JE, Burns J, Morris J, Hartley S, Martin LE, Choi IY, Lee P, Li Y, Hunt S, Sherman JR, Danon JC, Brucks MG, Koon L, Spaeth K, Sullivan DK.

Alzheimers Dement. 2025 Apr;21(4):e70219. doi: 10.1002/alz.70219.

Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's disease

Wisch JK, McKay NS, Zammit M, Christian BT, Schultz SA, Millar PR, Ryan NS, Cash DM, Belder CRS, Chrem P, Cruchaga C, Ibanez L, Jucker M, Yakushev I, Day GS, Murphy M, Llibre-Guerra J, Aguillon D, Roh JH, Xiong C, Wang G, Li Y, Schindler SE, Jack C, McDade E, Bateman RJ, Benzinger TLS, Ances BM; Dominantly Inherited Alzheimer Networ; Betthauser T, Gordon B.

Alzheimers Dement. 2025 Oct;21(10):e70812. doi: 10.1002/alz.70812.

Clinical Pharmacokinetics of Oral ALZ-801/Valiltramiprosate in a 2-Year Phase 2 Trial of APOE4 Carriers with Early Alzheimer's Disease

Hey JA, Yu JY, Abushakra S, Schaefer JF, Power A, Kesslak P, Paul J, Tolar M.

Clin Pharmacokinet. 2025 Mar;64(3):407-424. doi: 10.1007/s40262-025-01482-8. Epub 2025 Feb 5.

Biofluid-based biomarker panels toward personalized medicine in dementia diagnostics

Zetterberg H.

Alzheimers Dement. 2025 Jun;21(6):e70178. doi: 10.1002/alz.70178.

Association between inflammatory biomarkers and the cognitive response to a multidomain intervention: secondary longitudinal analyses from the MAPT study

Gonzalez-Bautista E, Soto M, Abellan van Kan G, Delrieu J.

Geroscience. 2025 Jun;47(3):5365-5376. doi: 10.1007/s11357-024-01497-2. Epub 2025 Jan 17.

Precision exercise in older adults with early Alzheimer's disease: The study protocol of the FIT-AD Sequential, Multiple Assignment, Randomized Trial (SMART)

Yu F, Todd M, Salisbury D, Maxfield M, Pruzin J, Joseph RP, Su Y, Li D, Baena E, Coon D.

Trials. 2025 Oct 15;26(1):416. doi: 10.1186/s13063-025-09040-0.

Multimodal Imaging Markers of Cognitive Resilience and Molecular Mechanisms of Brain Resilience in Alzheimer's Disease

Yang Z, Sheng J, Zhang Q, Zhao X, Song Y, Dong G, Zhang R, Zhao H, Wang J, Pan R, Zhu H.

J Integr Neurosci. 2025 May 16;24(5):26584. doi: 10.31083/JIN26584.

Methylated cell-free DNA as a novel biomarker in Alzheimer's disease

Zhen M, Dang M, Cao Z, Xia X, Peng F, Wang S, Liu Y.

Clin Chim Acta. 2025 Jan 30;566:120069. doi: 10.1016/j.cca.2024.120069. Epub 2024 Nov 30.

Unraveling Homocysteine's Role in Dementia: No Specific Association with Alzheimer's Disease, but a Connection to White Matter Hyperintensities

Decaix T, Lilamand M, Götze K, Mouton-Liger F, Cognat E, Hugon J, Bouaziz-Amar E, Sindzingre L, Dumurgier J, Paquet C.

Aging Dis. 2025 Mar 5;17(2):1084-1093. doi: 10.14336/AD.225.0020.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias